SCM
RLAY icon

Sterling Capital Management’s Relay Therapeutics RLAY Stock Holding History

Sterling Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
1,139
-3,526
-76% -$51.2K ﹤0.01% 1857
2026
Q1 		$46.4K Sell
4,665
-3,451
-43% -$30.9K ﹤0.01% 1671
2025
Q4 		$68.7K Sell
8,116
-1,021
-11% -$7.29K ﹤0.01% 1675
2025
Q3 		$47.7K Buy
9,137
+5,765
+171% +$22K ﹤0.01% 1766
2025
Q2 		$11.7K Buy
3,372
+1,186
+54% +$3.53K ﹤0.01% 2037
2025
Q1 		$5.73K Sell
2,186
-1,648
-43% -$6.46K ﹤0.01% 2095
2024
Q4 		$15.8K Buy
3,834
+3,483
+992% +$19K ﹤0.01% 1951
2024
Q3 		$2.48K Buy
+351
New +$2.62K ﹤0.01% 2085

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Sterling Capital Management's RLAY Position: Q2 2026 in Review

Sterling Capital Management reduced its Relay Therapeutics (RLAY) stake by 76% in Q2 2026, selling an estimated $51.2K and leaving 1,139 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Sterling Capital Management first reported a position in RLAY in Q3 2024 and has held it in 8 quarters since. The position peaked at $68.7K in Q4 2025. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Sterling Capital Management held 1,139 shares of Relay Therapeutics worth $21.3K as of Q2 2026.
  • Sterling Capital Management sold 3,526 Relay Therapeutics shares in Q2 2026, an estimated $51.2K.
  • Relay Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1857 holding.
  • Sterling Capital Management first reported a position in Relay Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Relay Therapeutics position peaked at $68.7K in Q4 2025.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.